-
Chattopadhyay R, Mahajan B, Kumar S, 2007: Assessment of safety of the major antimalarial drugs[J]. Expert Opin Drug Saf, 6, 505-521. doi: 10.1517/14740338.6.5.505
-
García-Serradilla M, Risco C, Pacheco B, 2019: Drug repurposing for new, efficient, broad spectrum antivirals[J]. Virus Res, 264, 22-31. doi: 10.1016/j.virusres.2019.02.011
-
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B, 2020: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, , -. doi: 10.1016/S0140-6736(20)30183-5
-
Lo MK, Jordan R, Arvey A, Sudhamsu J, Shrivastava-Ranjan P, Hotard AL, Flint M, McMullan LK, Siegel D, Clarke MO, Mackman RL, Hui HC, Perron M, Ray AS, Cihlar T, Nichol ST, Spiropoulou CF, 2017: GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses[J]. Sci Rep, 7, 43395-. doi: 10.1038/srep43395
-
National Health Commission of the People's Republic of China (2020) http://www.nhc.gov.cn/xcs/yqfkdt/202001/e71bd2e7a0824ca69f87bbf1bef2a3c9.shtml
-
Rainsford KD, Parke AL, Clifford-Rashotte M, Kean WF, 2015: Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases[J]. Inflammopharmacology, 23, 231-269. doi: 10.1007/s10787-015-0239-y
-
Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R, 2003: Effects of chloroquine on viral infections: an old drug against today's diseases[J]. Lancet Infect Dis, 3, 722-727. doi: 10.1016/S1473-3099(03)00806-5
-
Sheahan TP, Sims AC, Graham RL, Menachery VD, Gralinski LE, Case JB, Leist SR, Pyrc K, Feng JY, Trantcheva I, Bannister R, Park Y, Babusis D, Clarke MO, Mackman RL, Spahn JE, Palmiotti CA, Siegel D, Ray AS, Cihlar T, Jordan R, Denison MR, Baric RS, 2017: Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses[J]. Sci Trans Med, , -. doi: 10.1126/scitranslmed.aal3653
-
Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi ZL, Hu Z, Zhong W, Xiao G, 2020: Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro[J]. Cell Res, , -. doi: 10.1038/s41422-020-0282-0
-
Warren TK, Jordan R, Lo MK, Ray AS, Mackman RL, Soloveva V, Siegel D, Perron M, Bannister R, Hui HC, 2016: Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys[J]. Nature, 531, 381-385. doi: 10.1038/nature17180
-
World Health Organization (WHO) (2020a) https://www.who.int/csr/sars/en/. Accessed 29 Jan 2020
-
World Health Organization (WHO) (2020b) https://www.who.int/emergencies/mers-cov/en/. Accessed 29 Jan 2020
-
World Health Organization (WHO) (2020c) https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200129-sitrep-9-ncov-v2.pdf?sfvrsn=e2c8915_2. Accessed 29 Jan 2020
-
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W, 2020: China Novel Coronavirus Investigating and Research Team (2020) A novel coronavirus from patients with pneumonia in China, 2019[J]. N Engl J Med, , -. doi: 10.1056/NEJMoa2001017